Načítá se...
Improvement of Restless Legs Syndrome by Varenicline as Antismoking Treatment
Varenicline is a partial agonist at the α4β2 nicotinic acetylcholine receptor effective as smoking cessation pharmacotherapy. We present a familial case of severe restless legs syndrome (RLS) resistant to polytherapy who showed a consistent and effective amelioration of RLS symptoms after introducti...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Academy of Sleep Medicine
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3778182/ https://ncbi.nlm.nih.gov/pubmed/24127155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5664/jcsm.3092 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|